Treatment of PCNSL With R-IDARAM and Intrathecal Immunochemotherapy

Clinical trial NCT02657785 · RECRUITING

Trial details

NCT number: NCT02657785
Sponsor: Navy General Hospital, Beijing
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Primary Central Nervous System Lymphoma

Start date: 2010-09-01
Primary completion: 2028-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.